Erythropoiesis stimulatory agent- resistant anemia in dialysis patients: review of causes and management.


Despite new therapeutic options and treatment strategies, anemia still remains one of the major complications of chronic kidney disease (CKD), especially in patients undergoing chronic hemodialysis for end-stage renal disease. Successful management of anemia is a central part of patient care that may improve clinical outcomes. Although the National Kidney… (More)
DOI: 10.1159/000245041

3 Figures and Tables


  • Presentations referencing similar topics